Covaxin

COVID Vaccine: DCGI Approves Phase 2/3 Clinical Trial Of Covaxin In Age Group Of 2 To 18 Yrs

Vaccine Shortage: SII To Ramp Up Production To 10 Cr Doses By Aug, Bharat Biotech Promises 7.8 Cr Jabs

Covaxin Centres In Delhi Closed As Bharat Biotech Refused To Supply Vaccines On Centre's Directive: AAP

Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years

Fresh Orders Placed To Procure Covid-19 Vaccines, To Be Delivered By July: Hardeep Singh Puri

Veteran Actor Mohan Joshi Tests COVID-19 Positive After Taking Both Doses Of Vaccine

Vaccine Shortage In Delhi: Health Minister Alleges 'Covaxin To Last A Day, Covishield 3-4 Days'

Covid Vaccination Phase 3 Not Starting In Uttarakhand On May 1 Due To Supply Shortage, Says Official

Maharashtra Not Able To Commence Vaccination Drive For Age Group 18-44: Health Minister Cites Covid Vaccine Shortage

Bharat Biotech Slashes Covaxin Prices From Rs 600 To Rs 400 Per Dose For States

'Covaxin Can Neutralise 617 Variant Of Covid-19,' Claims Dr Fauci; US Working On Sending Supplies To India

'No Time To Earn Profit:' CM Kejriwal Appeals Centre, Manufacturers To Lower Covid Vaccine Prices